WTO/TRIPs, Pharmaceuticals and Health: Impacts and Strategies
Author(s)
Mirza, Zafar
Abstract
Zafar Mirza looks at the problems of high drug prices, low access to medicines and the weakening of the national pharmaceutical industry for the majority of the world’s population when the ‘Agreement on Trade-Related Aspects of Intellectual Property Rights’ (TRIPs) is to be implemented.
